The IL-17 cytokine (related to the lesion activity) was recently detected in the human serum of autoimmune diseases, and it is frequently high in blood and cerebrospinal fluid of MS individuals, who were not subjected to treatment with IFN, and reduced in remission periods [35]. The gene discussed is IFNA1; the disease is myeloid sarcoma.